Issue of Equity - Results of placing

RNS Number : 6249R
Honeycomb Investment Trust PLC
12 December 2016
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE OF THIS ANNOUNCEMENT WOULD BE UNLAWFUL.

12 December 2016

Honeycomb Investment Trust plc

Results of placing

Further to the announcement on 9 December 2016, Honeycomb Investment Trust plc (the "Company") is pleased to announce the successful completion of its placing of 4,926,109 ordinary shares in the Company (the "Placing Shares"), raising gross proceeds of £50 million. The Placing Shares are to be issued at a price of £10.15 per Placing Share.

Application will be made to the London Stock Exchange for the Placing Shares to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange ("Admission"). It is expected that Admission will become effective and that dealings in the Placing Shares will commence at 8.00 a.m. on 16 December 2016.

On Admission, the Company's issued share capital will comprise 19,926,110 ordinary shares of £0.01 each. The total number of voting rights in the ordinary shares is 19,926,110. There are no shares held in treasury.

ENQUIRIES

For further information, please contact:

Pollen Street Capital Limited

Lindsey McMurray / James Scott / Matthew Potter
020 3728 6750

Liberum Capital Limited

Chris Clarke / Henry Freeman / Robert Johnson
020 3100 2000

IMPORTANT NOTICE

Liberum Capital Limited, which is authorised and regulated by the FCA in the United Kingdom, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Liberum Capital Limited or advice to any other person in relation to the matters contained herein.

Neither Liberum Capital Limited nor Pollen Street Capital Limited, nor any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of, the information in this announcement (or whether any information has been omitted from the announcement) or any information relating to the Company, whether written, oral, or in a visual or electronic form, and howsoever transmitted or made available or any loss howsoever arising from any use of this announcement or its contents or otherwise in connection with it.

This announcement may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States.  This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States.  Securities may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The securities mentioned herein have not been, and will not be, registered under the Securities Act and will not be offered to the public in the United States.  The Company has not been, and will not be, registered under the US Investment Company Act of 1940, as amended.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEDLLFFQLFFFBX
UK 100

Latest directors dealings